Market Overview:
The global protein glutamine gamma glutamyltransferase 2 market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for personalized medicines. Based on type, the global protein glutamine gamma glutamyltransferase 2 market is segmented into CAT-5571, ERW-1041E, ZED-1227 and others. The CAT-5571 segment is expected to account for a major share of the global protein glutamine gamma glutamyltransferase 2 market in 2018. This can be attributed to its high specificity and sensitivity towards detecting mutations in proteins associated with various diseases such as cancer. Based on application, the global protein glutamine gamma glutamyltransferase 2 market is segmented into hospital care settings (including hospitals and clinics), research laboratories (including contract research organizations), biotechnology companies and others (includes point of care testing). In 2018, hospital care settings are estimated to dominate the global protein glutamate transferase2market owing to increasing number of patients suffering from chronic diseases that require regular monitoring for early diagnosis & treatment intervention.
Product Definition:
Protein glutamine gamma-glutamyltransferase 2 is an enzyme that helps to transfer the amino acid glutamine from one molecule to another. This enzyme is important for the metabolism of protein and helps to recycle nitrogen in the body.
CAT-5571:
The enzyme, Protein glutamine gamma glutamyltransferase 2 (POGG-T2), is an enzyme that catalyzes the transfer of a gamma-glutamyl residue from protein amino acid to glutamate. POGG-T2 has been studied in detail as a potential drug target for treating various central nervous system disorders such as multiple sclerosis and Alzheimer's disease.
ERW-1041E:
ERW-1041E is a selective and competitive inhibitor of the enzyme glutamic acid decarboxylase (GAD). GAD is an important enzyme for the body's immune system. The drug was developed by Eli Lilly and Company in 2002 as a potential treatment for multiple sclerosis, which is how it got its current name. However, despite being approved in many countries across the globe including U.S.
Application Insights:
The hospital application segment led the market and accounted for more than 60% of the global revenue share in 2017. The growing number of hospitals, rising prevalence of chronic diseases and increasing number of surgeries are some factors that boost product demand in hospital applications.
Clinic applications include medical centers, clinics and surgery centers. These institutions offer advanced healthcare services to a large patient base through various outpatient facilities. Hence, they require a high amount of protein glutamine gamma glutamyltransferase 2 as an essential enzyme to perform efficiently in their clinical routine procedures.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The region is expected to maintain its dominance during the forecast period owing to high healthcare spending, technological advancements, and an increase in aging population prone to chronic diseases. Moreover, rising demand for nutraceuticals and functional foods coupled with stringent regulations regarding gluten-free products are anticipated to drive regional growth over the coming years.
Asia Pacific is estimated to be one of the fastest growing regions during the forecast period due to increasing disposable income levels and awareness about early diagnosis of rare disorders such as glutamine gamma-glutamyltransferase 2 (GGT2). Furthermore, government initiatives aimed at improving healthcare infrastructure along with rising investment by multinational companies will also boost market development over this period.
Growth Factors:
- Increasing awareness about the benefits of Protein Glutamine Gamma Glutamyltransferase 2 for overall health and well-being.
- Growing demand from fitness enthusiasts and athletes for supplements that improve performance and muscle growth.
- Rising incidence of lifestyle diseases such as obesity, diabetes, and heart disease that can be managed with Protein Glutamine Gamma Glutamyltransferase 2 supplements.
- increasing research on the potential role of Protein Glutamine Gamma Glutamyltransferase 2 in preventing or managing chronic diseases such as cancer, Alzheimer's disease, and arthritis.
Scope Of The Report
Report Attributes
Report Details
Report Title
Protein Glutamine Gamma Glutamyltransferase 2 Market Research Report
By Type
CAT-5571, ERW-1041E, ZED-1227, Others
By Application
Hospital, Clinic, Others
By Companies
Catabasis Pharmaceuticals Inc, Zedira GmbH
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
150
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Protein Glutamine Gamma Glutamyltransferase 2 Market Report Segments:
The global Protein Glutamine Gamma Glutamyltransferase 2 market is segmented on the basis of:
Types
CAT-5571, ERW-1041E, ZED-1227, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Catabasis Pharmaceuticals Inc
- Zedira GmbH
Highlights of The Protein Glutamine Gamma Glutamyltransferase 2 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CAT-5571
- ERW-1041E
- ZED-1227
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Protein Glutamine Gamma Glutamyltransferase 2 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Protein Glutamine Gamma Glutamyltransferase 2 is an enzyme that catalyzes the transfer of a glutamic acid from one molecule of glutamate to another. This process helps to form proteins.
Some of the major companies in the protein glutamine gamma glutamyltransferase 2 market are Catabasis Pharmaceuticals Inc, Zedira GmbH.
The protein glutamine gamma glutamyltransferase 2 market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Protein Glutamine Gamma Glutamyltransferase 2 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Protein Glutamine Gamma Glutamyltransferase 2 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Protein Glutamine Gamma Glutamyltransferase 2 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Protein Glutamine Gamma Glutamyltransferase 2 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size & Forecast, 2020-2028
4.5.1 Protein Glutamine Gamma Glutamyltransferase 2 Market Size and Y-o-Y Growth
4.5.2 Protein Glutamine Gamma Glutamyltransferase 2 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 CAT-5571
5.2.2 ERW-1041E
5.2.3 ZED-1227
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Protein Glutamine Gamma Glutamyltransferase 2 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Protein Glutamine Gamma Glutamyltransferase 2 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 CAT-5571
9.6.2 ERW-1041E
9.6.3 ZED-1227
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 CAT-5571
10.6.2 ERW-1041E
10.6.3 ZED-1227
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 CAT-5571
11.6.2 ERW-1041E
11.6.3 ZED-1227
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 CAT-5571
12.6.2 ERW-1041E
12.6.3 ZED-1227
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 CAT-5571
13.6.2 ERW-1041E
13.6.3 ZED-1227
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Protein Glutamine Gamma Glutamyltransferase 2 Market: Competitive Dashboard
14.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Catabasis Pharmaceuticals Inc
14.3.2 Zedira GmbH
